Most recent articles by:
Pavlos Giorkas
Pavlos Giorkas is a blogger and content creator with a passion for crypto, health, consumer tech and money management. He's been dealing with cryptocurrency since 2013 but didn't take action until 3 years later on 2016. On Bitnewsbot he covers the latest news in the crypto space.
News
BRICS Accelerates Dollar Alternatives With Gold, New Payment Systems
BRICS nations are intensifying efforts to reduce reliance on the U.S. dollar by building new financial infrastructure.
The bloc holds over 6,000 tons of Gold,...
News
Pfizer Shares Jump After Trump Deal for Discounted Drug Sales
Pfizer reached an agreement with the U.S. government to offer major prescription drugs at steep discounts through a new federal online platform.
The deal led...
News
Sei Expands in Asia With Japan License, Eyes Institutional Growth
Sei obtained regulatory approval in Japan, enabling listings on major exchanges such as Binance Japan and OKX Japan.
Japan’s strict licensing was crucial for Sei's...
News
Federal Government Shuts Down as Senate Deadlocks on Funding
The U.S. government began a federal shutdown at 12:01 a.m. on October 1, 2025, after Congress failed to pass a funding bill.
This is the...
News
Apple Rejects Musk’s Claim of Favoritism in OpenAI Partnership
Apple is seeking the dismissal of an antitrust lawsuit filed by Elon Musk’s X Corp. regarding its partnership with OpenAI.The lawsuit claims that Apple...
News
Coinbase’s D’Agostino: AI Agents Need Crypto for Fast Finance
Crypto and blockchain technology are viewed as essential for Artificial Intelligence agents to operate effectively in modern financial markets.
John D’Agostino from Coinbase says traditional...
News
Pfizer Soars 6.8% as TrumpRx.gov Direct Drug Deal Slashes Prices
A new U.S. government platform will refer consumers directly to drug manufacturers starting in early 2026.
Pfizer is the first major pharmaceutical company to join...
News
Eli Lilly, Pfizer Surge as Trump Unveils Drug Price-Cut Plan
Eli Lilly shares surged over 5% after President Trump announced a new plan aiming to reduce U.S. drug prices.Pfizer agreed to the plan, committing...
